Stockholm-based Tandem Health, which offers clinicians an AI copilot that generates medical notes during patient consultations, raised a $100M Series B

Your doctor's ability to focus on you during appointments is improved by AI that writes notes. The price of AI for healthcare administration falls.

Tandem Health, a Stockholm-based healthtech startup, has successfully closed a $100 million Series B funding round. The round was led by a new investor, the EU-backed Scaleup Europe Fund, which manages €5 billion. Existing investors, including Kinnevik, Northzone, Amino Collective, and Visionaries, also participated. This significant Series B raise follows Tandem Health's $50 million Series A in 2025, bringing the company's total funding to $160 million. The valuation for this latest round was not disclosed by Tandem Health.

This substantial funding round signals strong investor confidence in AI-driven solutions for healthcare administration, particularly in automating the time-consuming task of medical note-taking. The involvement of a large EU-backed fund suggests a growing trend towards supporting European healthtech scaleups with significant capital to compete globally. Tandem Health's AI copilot aims to reduce clinician burnout by handling documentation, allowing them to dedicate more attention to patient care.

The success of Tandem Health's funding could spur increased competition and innovation in the clinical AI copilot space, potentially leading to more advanced features and broader adoption across healthcare systems. As more startups secure large investments, established EMR vendors may face pressure to integrate similar AI capabilities or risk losing market share. This trend highlights a critical shift towards leveraging AI to optimize operational efficiencies and enhance the physician-patient interaction within the healthcare industry.